C reactive protein and the risk of cardiovascular disease

BMJ

Volumn 342, Issue 7794, 2011, Pages 393-

  Keavney, Bernard ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; EDITORIAL; GENETIC VARIABILITY; HUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

C-REACTIVE PROTEIN; CORONARY DISEASE; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 79951969403     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d144     Document Type: Editorial

References (12)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26. (Pubitemid 29054847)
2. Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, Collins R, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375:132-40.
3. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
4. C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC). Association between C reactive protein and coronary disease: mendelian randomisation analysis based on individual participant data. BMJ 2011;342:d548.
5. Kaul S, Morrissey RP, Diamond GA. By Jove! What is a clinician to make of JUPITER? Arch Intern Med 2010;170:1073-7.
6. Ridker PM, Glynn RJ. The JUPITER Trial: responding to the critics. Am J Cardiol 2010;106:1351-6.
7. Keavney B. Commentary: Katan's remarkable foresight: genes and causality 18 years on. Int J Epidemiol 2004;33:11-4. (Pubitemid 38500147)
8. Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, et al. Fibrinogen and coronary heart disease: test of causality by "Mendelian randomization." Int J Epidemiol 2006;35:935-43.
9. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009;302:37-48.
10. Brunner EJ, Kivimaki M, Witte DR, Lawlor DA, Davey Smith G, Cooper JA, et al. Inflammation, insulin resistance, and diabetes - Mendelian randomization using CRP haplotypes points upstream. PLoS Med 2008;5:e155.
11. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006;440:1217-21.
12. Ridker PM. Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). J Thromb Haemost 2009;7(suppl 1):332-9.